← Back to Search

Psychosocial Support Interventions for Pediatric Cancer (PAT Trial)

N/A

Waitlist Available

Research Sponsored by Nemours Children's Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 and 12 months

Awards & highlights

PAT Trial Summary

This trial will study two ways to help pediatric cancer programs provide better psychological support to patients and families.

Who is the study for?

This trial is for pediatric cancer programs in the U.S. that have a psychosocial staff size at or above the median level. Eligible sites must serve a significant number of new pediatric cancer patients, including Spanish speakers and families with low socioeconomic status.Check my eligibility

What is being tested?

The study compares two strategies to implement the Psychosocial Assessment Tool (PAT) across 18 pediatric cancer centers. One group will receive Training Webinar Plus Implementation Enhanced Resources (TIER), while another just gets a training webinar.See study design

What are the potential side effects?

Since this trial focuses on implementing an assessment tool rather than medical treatment, it does not involve direct physical side effects. However, there may be indirect impacts on patient care based on how well each strategy works.

PAT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of Intervention Measure (AIM)

Ethnic minority families screened

Families provided feedback

+6 more

PAT Trial Design

2Treatment groups

Active Control

Group I: Strategy I.TrainingActive Control1 Intervention

Sites randomized to Strategy I will receive a three hour training webinar in preparing for implementation of the PAT in their center.

Group II: Strategy II.Training+Implementation Enhanced Resources (TIER)Active Control2 Interventions

Sites randomized to Strategy II will identify a Champion for screening and will participate in a monthly consultation call in addition to completing the three hour training webinar for implementing the PAT in their center.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Nemours Children's ClinicLead Sponsor

124 Previous Clinical Trials

18,113 Total Patients Enrolled

Children's Hospital of PhiladelphiaOTHER

708 Previous Clinical Trials

8,581,257 Total Patients Enrolled

American Cancer Society, Inc.OTHER

224 Previous Clinical Trials

110,437 Total Patients Enrolled

Media Library

Strategy I.Training Clinical Trial Eligibility Overview. Trial Name: NCT04446728 — N/A

Pediatric Cancer Research Study Groups: Strategy I.Training, Strategy II.Training+Implementation Enhanced Resources (TIER)

Pediatric Cancer Clinical Trial 2023: Strategy I.Training Highlights & Side Effects. Trial Name: NCT04446728 — N/A

Strategy I.Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04446728 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the estimated size of the participants in this research project?

"Yes, according to the latest data on clinicaltrials.gov, this medical research project is currently recruiting patients. It was initially posted on January 1st 2021 and recently revised on September 1st 2021. The team needs 18 volunteers from one site in particular."

Answered by AI

Is patient enrollment still open for this scientific exploration?

"Affirmative. According to clinicaltrials.gov, the trial in question is actively recruiting participants who have met the criteria since being posted on January 1st 2021; it was recently updated on September 1st 2021 and requires 18 individuals from a single site."

Answered by AI

Recent research and studies

Implementation ScienceJournal

Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer with the Psychosocial Assessment Tool (PAT): Study Protocol for a Cluster-randomized Comparative Effectiveness Trial

Kazak, Anne E., Janet A. Deatrick, Michele A. Scialla, Eric Sandler, Rebecca E. Madden, and Lamia P. Barakat. 2020. “Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer with the Psychosocial Assessment Tool (PAT): Study Protocol for a Cluster-randomized Comparative Effectiveness Trial”. Implementation Science. Springer Science and Business Media LLC. doi:10.1186/s13012-020-01023-w.

Implementation Science CommunicationsJournal

Using Qualitative and Participatory Methods to Refine Implementation Strategies: Universal Family Psychosocial Screening in Pediatric Cancer

Deatrick, Janet A., Anne E. Kazak, Rebecca E. Madden, Glynnis A. McDonnell, Katherine Okonak, Michele A. Scialla, and Lamia P. Barakat. 2021. “Using Qualitative and Participatory Methods to Refine Implementation Strategies: Universal Family Psychosocial Screening in Pediatric Cancer”. Implementation Science Communications. Springer Science and Business Media LLC. doi:10.1186/s43058-021-00163-4.

Psycho-OncologyJournal

Advancing Health Equity in Pediatric Cancer Through Implementation of Universal Family Psychosocial Risk Screening

Deatrick, Janet A., Anne E. Kazak, Michele A. Scialla, Rebecca E. Madden, Glynnis A. McDonnell, Katherine Okonak, and Lamia P. Barakat. 2022. “Advancing Health Equity in Pediatric Cancer Through Implementation of Universal Family Psychosocial Risk Screening”. Psycho-oncology. Wiley. doi:10.1002/pon.5978.

Psycho-OncologyJournal